Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
Bladder cancer (BLCA) is one of the most prevalent malignancies of the urinary system, prone to recurrence, metastasis, and drug resistance. Its complex biological characteristics underscore the need ...
I Overview of establishment of BC-PD-L1. (A) Overview of the models of BCCs for potential applications in prediction of prognosis in bladder cancer. Urine/tumor samples were collected from BLCA ...
Incidence of other multiple primary malignancies in patients with adrenocortical carcinoma. Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results